These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 26845209)

  • 21. Tubular lesions predict renal outcome in antineutrophil cytoplasmic antibody-associated glomerulonephritis after rituximab therapy.
    Berden AE; Jones RB; Erasmus DD; Walsh M; Noël LH; Ferrario F; Waldherr R; Bruijn JA; Jayne DR; Bajema IM;
    J Am Soc Nephrol; 2012 Feb; 23(2):313-21. PubMed ID: 22095945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis C virus infection, mixed cryoglobulinemia, and kidney disease.
    Fabrizi F; Plaisier E; Saadoun D; Martin P; Messa P; Cacoub P
    Am J Kidney Dis; 2013 Apr; 61(4):623-37. PubMed ID: 23102733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of HCV-associated cryoglobulinemic glomerulonephritis].
    Laurino S; Borrelli S; Catapano F; Mascia S; D'Angio' P; Calabria M; Grimaldi M; Salvio A; Minutolo R; De Nicola L; Conte G
    G Ital Nefrol; 2009; 26(3):318-27. PubMed ID: 19554529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of Covariates Modulating B-Cell Repopulation Kinetics in Subjects Receiving Rituximab Treatment.
    Welte T; Westermann L; Kappes J; Schramm MA; Bemtgen X; Staudacher DL; Hug MJ; Venhoff N; Arnold F
    Arthritis Rheumatol; 2023 Nov; 75(11):2045-2053. PubMed ID: 37276446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rituximab in primary membranous nephropathy: first-line therapy, why not?
    Cravedi P; Remuzzi G; Ruggenenti P
    Nephron Clin Pract; 2014; 128(3-4):261-9. PubMed ID: 25427622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapy of hepatitis C virus-associated glomerulonephritis: current approaches.
    Fabrizi F; Lunghi G; Messa P; Martin P
    J Nephrol; 2008; 21(6):813-25. PubMed ID: 19034865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis.
    Roccatello D; Baldovino S; Rossi D; Mansouri M; Naretto C; Gennaro M; Cavallo R; Alpa M; Costanzo P; Giachino O; Mazzucco G; Sena LM
    Nephrol Dial Transplant; 2004 Dec; 19(12):3054-61. PubMed ID: 15494358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ANCA-positive pauci-immune rapidly progressive glomerulonephritis and the nephrotic syndrome.
    Jabur WL; Saeed HM
    Saudi J Kidney Dis Transpl; 2010 May; 21(3):526-30. PubMed ID: 20427883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cryoglobulinaemia type III with severe neuropathy and immune complex glomerulonephritis: remission after plasmapheresis and rituximab.
    Braun A; Neumann T; Oelzner P; Hein G; Gröne HJ; Ziemer M; Wolf G
    Rheumatol Int; 2008 Mar; 28(5):503-6. PubMed ID: 17924113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal involvement in anti-neutrophil cytoplasmic autoantibody associated vasculitis.
    Sinico RA; Di Toma L; Radice A
    Autoimmun Rev; 2013 Feb; 12(4):477-82. PubMed ID: 22921791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rituximab treatment for a patient with type I cryoglobulinemic glomerulonephritis.
    Pandrangi S; Singh A; Wheeler DE; Rossi NF
    Nat Clin Pract Nephrol; 2008 Jul; 4(7):393-7. PubMed ID: 18493239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Controversial issues in the Giornale Italiano di Nefrologia: how to treat patients with focal segmental glomerular sclerosis].
    Passerini P; Scolari F; Frasca' GM; Leoni A; Venturelli C; Dallera N; Ravera S; Balestra E; Freddi P; Fanciulli E; D'Arezzo M; Sagripanti S
    G Ital Nefrol; 2009; 26(5):563-76. PubMed ID: 19802802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab.
    Stasi R; Stipa E; Del Poeta G; Amadori S; Newland AC; Provan D
    Rheumatology (Oxford); 2006 Nov; 45(11):1432-6. PubMed ID: 16632482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rituximab in the treatment of anti-neutrophil cytoplasm antibody-associated vasculitis.
    Jones RB
    Nephron Clin Pract; 2014; 128(3-4):243-9. PubMed ID: 25401382
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rituximab treatment for glomerulonephritis in HCV-associated mixed cryoglobulinaemia: efficacy and safety in the absence of steroids.
    Quartuccio L; Soardo G; Romano G; Zaja F; Scott CA; De Marchi G; Fabris M; Ferraccioli G; De Vita S
    Rheumatology (Oxford); 2006 Jul; 45(7):842-6. PubMed ID: 16418196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. S2. Rituximab for ANCA-associated vasculitis: the UK experience.
    Jayne D
    Presse Med; 2013 Apr; 42(4 Pt 2):532-4. PubMed ID: 23490639
    [No Abstract]   [Full Text] [Related]  

  • 37. Biological drugs in ANCA-associated vasculitis.
    Lutalo PM; D'Cruz DP
    Int Immunopharmacol; 2015 Aug; 27(2):209-12. PubMed ID: 25907243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis.
    Guillevin L; Pagnoux C; Karras A; Khouatra C; Aumaître O; Cohen P; Maurier F; Decaux O; Ninet J; Gobert P; Quémeneur T; Blanchard-Delaunay C; Godmer P; Puéchal X; Carron PL; Hatron PY; Limal N; Hamidou M; Ducret M; Daugas E; Papo T; Bonnotte B; Mahr A; Ravaud P; Mouthon L;
    N Engl J Med; 2014 Nov; 371(19):1771-80. PubMed ID: 25372085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nine patients with anti-neutrophil cytoplasmic antibody-positive vasculitis successfully treated with rituximab.
    Eriksson P
    J Intern Med; 2005 Jun; 257(6):540-8. PubMed ID: 15910558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rituximab in Children with Steroid-Dependent Nephrotic Syndrome: A Multicenter, Open-Label, Noninferiority, Randomized Controlled Trial.
    Ravani P; Rossi R; Bonanni A; Quinn RR; Sica F; Bodria M; Pasini A; Montini G; Edefonti A; Belingheri M; De Giovanni D; Barbano G; Degl'Innocenti L; Scolari F; Murer L; Reiser J; Fornoni A; Ghiggeri GM
    J Am Soc Nephrol; 2015 Sep; 26(9):2259-66. PubMed ID: 25592855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.